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Objective: To evaluate the essential oil composition and the anti-inﬂammatory activity
of Cymbopogon validus (C. validus) leaves and ﬂowers.
Methods: A total of 300 g of fresh or dry (leaves and ﬂowers) of C. validus were cut into
small pieces and subjected to hydro-distillation method for approximately 5 h using the
Clevenger apparatus. The extracted essential oils were then used for testing the anti-
inﬂammatory activity. The anti-inﬂammatory activity was evaluated by using egg albu-
min-induced paw edema.
Results: The extracted oils had the following yields 2.2% for fresh leaves, 2.0% for dry
leaves and 2.4% v/w for dry ﬂowers. GC–MS results revealed that the oils contained
artemisia ketone (37.5%), linalool (3.2%–29.6%), northujane (4.4%–16.8%), verbenone
(13.5%), naphthalene (1.7%–9.6%), d-cadinene (0.5%–8.1%), hedycaryol (5.4%–7.6%)
and a-eudesmol (6.5%–6.7%) as the major constituents. C. validus essential oils showed
signiﬁcant (P < 0.05) anti-inﬂammatory effects from the ﬁrst 30 min after albumin in-
jection compared to aspirin which had a later onset of effect.
Conclusions: The ﬁndings of this study show that the essential oil extracted from
C. validus fresh or dry leaves and ﬂowers have anti-inﬂammatory properties; that might
be associated with the major components and the minor components found in the
essential oils.1. Introduction
Cymbopogon genus is one of the most important essential oil
yielding genera of the Poaceae family [1]. It comprises of about 180
species, sub species, varieties as well as sub varieties [2].
Cymbopogon species are scattered all around the world and more
than 52 species are said to be found in Africa, 45 in India, 6 in
Australia and South America, 4 in Europe, 2 in North America
and the remaining species are dispersed in South Asia [3]. The
plants' essential oils are known for their pleasant aromas which
are used to ﬂavor foods and beverages; and as fragrances incosmetic and pharmaceutical industries [4]. The oils are also used
in household products and tobacco [5]. Numerous extracts and
essential oils extracted from these plants have been tested for
repellent and insecticidal properties using different types of
arthropods; they have also been used to cure several infectious
diseases that are engendered by bacteria, fungi, protozoa and
virus. People from the jungle regions of Bolivia Amazon use
Cymbopogon plants as repellents against mosquitoes [6]. Essential
oils from Cymbopogon species like Cymbopogon ﬂexuous
(C. ﬂexuous), Cymbopogon citratus (C. citratus), Cymbopogon
martini (C. martini), Cymbopogon winterianus (C. winterianus),
Cymbopogon nardus (C. nardus), Cymbopogon giganteus
(C. giganteus), Cymbopogon schoenanthus (C. schoenanthus)
and Cymbopogon parkeri (C. parkeri) contain monoterpenoid
components such as geraniol and citronellol which are considered
dominant in the oils; while the C. ﬂexuous oils and that of
C. parkeri shows the prevalence of sesquiterpenoids such as
isontermedeol. The essential oil of Cymbopogon species alsoticle under the CC BY-NC-ND license (http://
Pamela Rungqu et al./Asian Paciﬁc Journal of Tropical Medicine 2016; 9(5): 426–431 427reveals that the citral chemotype is common in Cymbopogon
pendulus (C. pendulus), C. ﬂexuous and C. citratus [7].
Cymbopogon validus (C. validus) (Stapf) Stapf ex Burtt Davy
is commonly known as a turpentine grass or the African Blue
Grass in South Africa, and the Afrikaner people call it ‘Reuse
Terpentynegras’. This species belongs to the Poaceae family and
has been described as a tufted perennial with culms up to 2.4 m
tall. Normally C. validus is found in mountainous grasslands and
also in the high-rainfall areas of South Africa where it is known to
grow in wet sites, along roads and on the margins of tree com-
munities [8]. It is widespread in the Eastern Cape and is often used
as durable thatch [4,8]. C. validus oil is pure therapeutic quality
aromatherapy essential oil that is produced by using wild-
crafted plants and traditional methods from South Africa [9].
Essential oils from C. validus are used as astringents, skin
toners and are also used in anti-aging preparation for men;
these essential oils also have anti-fungal, antiseptic, as well as
anti-viral properties. The oils are also popularly used as a
soothing foot bath. C. validus essential oils and decoctions are
used traditionally as anti-rodent, vermifuge, emetic, anti-
infective, and anti-plasmodic; they also help in treating morn-
ing sickness [2,7]. Chagonda et al [7] reported that the major
components from wild C. validus essential oils from Zimbabwe
were myrcene (23.1%–35.6%), (E)-b-ocimene (10.3%–11.5%),
geraniol (3.4%–8.3%), linalool (3.2%–3.7%) and camphene
(5.2%–6.0%); in cultivated C. validus essential oils myrcene
(11.6%–20.2%), (E)-b-ocimene (6.0%–12.2%), borneol (3.9%–
9.5%), geraniol (1.7%–5.0%) and camphene (3.3%–8.3%) were
the major components. Naidoo also revealed that C. validus
essential oils from Durban contained a-cubenene, camphene,
citronellal, geraniol, limonene, palmitic acid and sabinene as
the major components [10]. The study was aimed at extracting
essential oils from both (fresh and dry) parts of C. validus
ﬂowers and leaves, to determine their chemical proﬁle,
characterize the oils for medicinal and then evaluate the
biological potential of the oils as anti-inﬂammatory agents.
2. Materials and methods
2.1. Plant material
C. validus was collected in the month of April 2013 at the
Komga road, near King William's Town. The plants were
taxonomically identiﬁed by Dr T. Dold and the voucher spec-
imen was deposited in Selmar Schonland Herbarium Grahams-
town (GRA) at Rhodes University and the collection number
was PR/PL 02.
2.2. Extraction of essential oils
A total of 300 g of fresh or dry (leaves and ﬂowers) of the
plant material were cut into small pieces and subjected to hydro-
distillation method for approximately 5 h using the Clevenger
apparatus. The extracted essential oils were stored in sealed
sample vials and stored in a refrigerator at 4 C until the time of
analysis and bioassays.
2.3. Analysis of essential oils
GC-FID was performed on a HP5890-Ⅱ instrument, equipped
with a DB-5MS (30 m × 0.25 mm; 0.25 mm ﬁlm thickness) fusedsilica capillary column. Hydrogen was used as carrier gas
adjusted to a linear velocity of 32 cm/s (measured at 100 C).
Split ﬂow was adjusted to give a 20:1 ratio and septum sweep
was a constant 10 mL/min. The oven was programmed as fol-
lows: 60 C-240 C at 3 C/min. The samples were injected using
the splitless technique using 2 mL of oil in hexane (2:1000).
Injector and detector were set at 250 C. The GC was equipped
with FID and connected with to an electronic integrator HP 5896
Series Ⅱ. The percentage of the samples was computed from the
GC peak areas without using correction for response factors.
GC–MS was performed on a Hewlett Packard-6890
system equipped with a HP-5MS fused capillary column
(30 m × 0.25 mm; 0.25 mm ﬁlm thickness), coupled to a se-
lective mass detector Hewlett Packard-5973. Helium (1 mL/min)
was used as carrier gas; oven temperature program: 60 C–
240 C at 3 C/min; splitless during 1.50 min; sample volume
2 mL of the oil solution in hexane (2:1000). Injector and detector
temperature was 250 C. EIMS: electron energy, 70 eV; ion
source temperature and connection parts: 180 C.
2.4. Identiﬁcation of compounds
Identiﬁcation of compounds was done by matching their
mass spectra and retention indices with those recorded in
NIST11 library and by comparison of retention indices and mass
spectra with literature values [11–13].
2.5. Bio-assay (anti-inﬂammation)
Both female and male Wistar rats weighing 195–240 g were
used. The rats were obtained from the South African Vaccine
Producers and were housed in the animal holding facility at the
Zoology Department of Walter Sisulu University in Mthatha.
Ethical clearance for the study was obtained from the Walter
Sisulu University Research Ethics Committee DVC (AA&R)/
DRD/SREC: Reference No: 31. The animals were kept under
standard conditions with each cage housing 5 rats; room tem-
perature was maintained at 24 C and lighting was by daylight
only. Animals had free access to food and water throughout
except 8 h before experimentation when animals were only
given only water. A total of 5 rats were randomly assigned to
one of 5 groups, control group treated with 1 mL 0.09% NaCl,
standard group treated with 100 mg/kg Aspirin, C.V.F.L group
treated with 1 mL of 2% essential oil from fresh leaves of
C. validus, C.V.D.L group treated with 1 mL of 2% essential oil
from dry leaves of C. validus and C.V.D.F group treated with
1 mL of 2% essential oil from dry ﬂowers of C. validus. All
treatments were administered in 1 mL volumes.
Aspirin was procured from Reckitt Benckiser Pharmaceutical
(PTY) LTD/(EDMS) BPK Elandsfontein – South Africa.
2.6. Anti-inﬂammatory activity: fresh egg albumin-
induced right hind paw edema
Animals were randomly distributed to one of the 5 groups as
indicated earlier. Baseline right hind paw diameter (paw size)
was determined for each rat using a pair of YATO digital caliper
[14–17]. Rats were administered with oral doses of drugs as per
assigned group. A total of 30 min later the right hind paw of
each rat was injected with 1 mL of 50% (v/v) fresh egg
albumin. Paw sizes were again measured 30, 60, 90 and
Table 2










Monoterpenes 8.6 1.9 1.9
Oxygenated monoterpenes 55.4 31.0 28.0
Sesquiterpenes 5.4 3.1 11.9
Oxygenated sesquiterpenes 1.8 41.1 29.3
Others 14.0 14.2 18.5
Total identiﬁed 85.2 91.3 89.6
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calculated as:
D paw size = paw size after albumin injection at pre-determined
times − paw size before albumin injection.
2.7. Statistical analysis
One way of Analysis with Turkey-Kramer Multiple Com-
parisons Test was performed using GraphPadInstat (version 3.05
for Windows 95, GraphPad Software, San Diego California
USA, www.graphPad.com) to determine the difference between
each treatment group and control. The P value for the overall
relationship was 0.001 and was considered signiﬁcant. Results
were expressed as mean ± standard error of the mean.
3. Results
3.1. Chemical composition of essential oils
The pale yellow oils extracted from C. validus had a pleasant
odor. The percentage yields were as follows 2.2% v/w for fresh
leaves, 2.0% v/w for dry leaves and 2.43% v/w for dry ﬂowers.
Table 1 presents the examined constituents of the essential oils
as well as their percentage compositions. A total of 32 compo-
nents were identiﬁed in the essential oil of C. validus; 17
components accounted for 85.2% in fresh leaves, 20 components
for 91.3% in dry leaves and 16 components for 89.6% in dryTable 1
Chemical constituents from different parts of C. validus essential oil extracts
No Constituents RIa RIb Fresh leaves (%)
1 Northujane 859 859 4.4
2 Camphene 953 946 –
3 Sabinene 976 969 1.5
4 Myrcene 991 988 4.1
5 a-Phellandrene 1005 1002 2.2
6 Artemisia ketone 1062 1056 37.5
7 cis-Linalool oxide 1074 1067 –
8 m-Cymene 1082 1082 0.8
9 Linalool 1098 1095 3.2
10 Naphthalene 1179 1178 9.6
11 a-Terpineol 1189 1186 0.5
12 Verbenone 1204 1204 13.5
13 Carvone 1242 1239 0.7
14 a-Cubebene 1351 1345 0.7
15 a-Longipinene 1351 1350 –
16 Cyclosativene 1368 1369 –
17 b-Elemene 1375 1389 –
18 b-Cubebene 1390 1387 2.3
19 b-Caryophyllene 1418 1418 1.9
20 a-Muurolene 1499 1500 –
21 b-Dihydroagarofuran 1504 1499 –
22 Germacrene D-4-ol 1511 1574 0.6
23 d-Cadinene 1524 1522 0.5
24 Hedycaryol 1530 1546 –
25 Elemol 1547 1548 –
26 Globulol 1576 1590 –
27 Caryophyllene oxide 1581 1582 1.2
28 Guaiol 1595 1600 –
29 g-Eudesmol 1630 1630 –
30 Cubenol 1642 1645 –
31 b-Eudesmol 1649 1649 –
32 a-Eudesmol 1652 1652 –
RIa: retention indices on HP-5MS capillary column.
RIb: literature retention indices [18].
MSc: identiﬁcation based on mass spectral data.
RId: identiﬁcation on the basis of NIST11 library and comparison with literﬂowers. The main components identiﬁed in the essential oil of
C. validus fresh leaves were artemisia ketone (37.5%), verbe-
none (13.5%), naphthalene (9.6%) and northujane (4.4%);
linalool (29.6%), northujane (12.3%), d-cadinene (8.1%) and a-
eudesmol (6.7%) were the major components in dry leaves;
while in dry ﬂowers linalool (28.0%), northujane (16.8%),
hedycaryol (7.6%) and a-eudesmol (6.5%) were the major
components. The GC–MS results also showed that the fresh
leaves oil of C. validus contained 8.6% monoterpenes, 55.4%
oxygenated monoterpenes, 5.4% sesquiterpenes, 1.8% oxygen-
ated sesquiterpenes, 14% others in fresh leaves; while in dry
leaves the oils were mostly composed of 1.9% monoterpenes,
31.0% oxygenated monoterpenes, 3.1% sesquiterpenes, 41.1%
oxygenated sesquiterpenes, 14.2% other. C. validus dry ﬂower's
oil was mostly composed of 1.9% monoterpenes, 28.0%
oxygenated monoterpenes, 12.0% sesquiterpenes and 29.6%
oxygenated sesquiterpenes and 18.5% other (Table 2)..
Dry leaves (%) Dry ﬂowers (%) Identiﬁcation method
12.3 16.8 MSc, RId
0.6 – MSc, RId
– – MSc, RId
1.3 1.9 MSc, RId
– – MSc, RId
– – MSc, RId
1.4 – MSc, RId
– – MSc, RId
29.6 28.0 MSc, RId
1.9 1.7 MSc, RId
– – MSc, RId
– – MSc, RId
– – MSc, RId
2.7 – MSc, RId
– 2.8 MSc, RId
0.9 – MSc, RId
1.2 1.5 MSc, RId
– – MSc, RId
MSc, RId
1.0 1.2 MSc, RId
2.4 6.4 MSc, RId
– – MSc, RId
8.1 – MSc, RId
5.4 7.6 MSc, RId
2.2 1.8 MSc, RId
– 1.7 MSc, RId
1.9 – MSc, RId
2.3 1.5 MSc, RId
4.0 4.5 MSc, RId
3.5 4.1 MSc, RId
1.9 1.6 MSc, RId
6.7 6.5 MSc, RId
ature data.
Figure 1. Anti-inﬂammatory effects of C. validus oil (fresh and dry leaves and dry ﬂowers) on albumin-induced paw edema, at different time of inhibition.
*P < 0.05, **P < 0.01 compared to control animals.
Figure 2. Anti-inﬂammatory effects of C. validus oil (fresh and dried leaves; and fresh buds and dried buds) on fresh egg albumin-induced paw edema, at
different time of inhibition.
*P < 0.05, **P < 0.01 compared to aspirin treated animals.
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Figure 1 illustrated the anti-inﬂammation effects of essential
oils of C. validus on fresh egg albumin-induced inﬂammation:
measured 30, 60, 90 and 120 min after injection of the phlogistic
agent. All the essential oils showed signiﬁcant (P < 0.01) anti-
inﬂammatory effects from 30 to 120 min. Results obtained
with essential oils were better than those obtained with aspirin
during the experimental period. On the other hand Figure 2
showed a comparison of the anti-inﬂammatory effect of
aspirin with oils from fresh; dry leaves and dry ﬂowers of
C. validus. The fresh leaves oil showed signiﬁcantly (P < 0.05
and P < 0.01) greater anti-inﬂammatory effect compared to
aspirin throughout the experimental period. Essential oil from
the dry ﬂowers also showed signiﬁcantly (P < 0.05) greater
effects than aspirin during the 60 and 120 min while the anti-
inﬂammatory effects of oil from dry leaves was not different
from results obtained with aspirin.
4. Discussion
4.1. Chemical composition of essential oils
GC/MS results revealed that the oils contained artemisia
ketone (37.5%), linalool (3.2%–29.6%), northujane (4.4%–
16.8%), verbenone (13.5%), naphthalene (1.7–9.6%), d-cadi-
nene (0.5%–8.1%), hedycaryol (5.4%–7.6%) and a-eudesmol(6.5%–6.7%) as the major components. The GC/MS results also
revealed that oxygenated monoterpenes represented 5 of the 32
compounds corresponding to 55.4% of the fresh leaves oil,
oxygenated sesquiterpenes represented 11 of the 32 compounds
corresponding to 41.1% of the dry leaves, while the dry ﬂower's
oil represented 8 of the 32 compounds corresponding to 29.3%.
The main constituents in our C. validus essential oil were quite
different from the C. validus essential oil derived from
Zimbabwe and Durban. For example, Chagonda et al reported
that the essential oil of wild C. validus from Zimbabwe had the
following major constituents myrcene (23.1%–35.6%), (E)-b-
ocimene (10.3%–11.5%), geraniol (3.4%–8.3%), linalool
(3.2%–3.7%) and camphene (5.2%–6.0%) while in cultivated
C. validus essential oil myrcene (11.6%–20.2%), (E)-b-ocimene
(6.0%–12.2%), borneol (3.9%–9.5%), geraniol (1.7%–5.0%)
and camphene (3.3–8.3%) as major constituents [7]. Naidoo
revealed that the essential oil of C. validus from Durban
had a-cubenene, camphene, citronellal, geraniol, limonene,
palmitic acid and sabinene as major constituents [10]. When
comparing our results to the essential oil of C. validus
reported by Chagonda et al and Naidoo [7,10], it was observed
that our C. validus essential oil showed a very distinct
composition which was mainly characterized artemisia ketone
(37.5%), linalool (3.2%–29.6%), northujane (4.4%–16.8%),
verbenone (13.5%), naphthalene (1.7%–9.6%), d-cadinene
(0.5%–8.1%), hedycaryol (5.4%–7.6%) and a-eudesmol
(6.5%–6.7%). It was also observed that our C. validus
Pamela Rungqu et al./Asian Paciﬁc Journal of Tropical Medicine 2016; 9(5): 426–431430essential oil comprised of oxygenated monoterpenes as their
major oil constituents, while the essential oil of C. validus
from Durban consisted of more than 50% of sesquiterpene
constituents [10]; Chagonda et al found that the oils from the
wild and cultivated C. validus predominately comprised of
monoterpenes [7]. Then it was concluded that the 3 plants
from 2 different provinces (Eastern Cape and Kwazulu Natal)
and one from Zimbabwe are 3 different chemotypes of the
same plant species. The observed difference in chemical
composition and content of the essential oil of C. validus
could be due to climatic and soil variation, stage of vegetative
cycle and seasonal variation [19], literature does support the
identiﬁcation of different chemotypes of plant species based
on variation of their chemical constituents. Therefore, our
results support the fact that plant species from the same genus
can differ because of their geographical location.
4.2. Anti-inﬂammatory activity
The anti-inﬂammatory effect of C. validus essential oils in
Wistar rats using the fresh egg albumin-induced rat paw edema
model was analyzed. The essential oil from C. validus (i.e.
fresh; dry leaves and dry ﬂowers) showed anti-inﬂammatory
action by reducing the paw volume signiﬁcantly (P < 0.05
and P < 0.01). Fresh egg albumin-induced inﬂammation oc-
curs in 3 phases. An initial phase during the ﬁrst 1.5 h is
caused by the release of histamine and serotonin [20]. The
second phase involves the release of bradykinin from 1.5 h
to 2.5 h, whilst the third phase involves the release of
prostaglandins and that occurs from 2.5 h to 6.0 h after
albumin injection [21]. The current study lasted for only
120 min due to rapid resolution of inﬂammation. This
corresponds to the ﬁrst phase of inﬂammation, indicating
that the oil from the fresh; dry leaves and dry ﬂowers of
C. validus exert their anti-inﬂammatory properties by inhibit-
ing the release of histamine and serotonin. C. validus essential
oils exhibited signiﬁcant (P < 0.01) anti-inﬂammatory activity
as compared to the control group throughout the 2 h period
of experimentation. Aspirin showed no effectiveness during
the ﬁrst 30 min, but it was effective (P < 0.05) at 60, 90 and
120 min. Linalool, a major constituent in the oil could
have contributed to the observed anti-inﬂammatory effects.
Indeed a few studies have revealed an effect of (−) – Linalool
on chronic inﬂammation, which signiﬁcantly reduced Com-
plete Freund's Adjuvant induced paw edema at a dose of
200 mg/kg [22–25]. Artemisia ketone could also be attributed
with the anti-inﬂammatory effect of the oil as other studies
reveal that ketones can reduce pain and inﬂammation [26]. This
inhibition may also be associated to the presence of a-
eudesmol, naphthalene and d-cadinene for example previous
reports reveal that a-eudesmol was responsible for the
inhibition of neurogenic inﬂammation in models of the
electrical stimulation [27], while naphthalene derivatives are
currently used for the treatment of inﬂammatory disorders
[28]; Moreover, d-cadinene which was one of the main
components in the Teucrium essential oil exhibited anti-
inﬂammatory activity [29]. Contents of essential oil from
C. validus may exert their effects by inhibiting the release of
mediators such as histamine and serotonin during the ﬁrst
phase. Thus, both fresh and dry parts of the plant proved to
have signiﬁcant anti-inﬂammatory properties.Conﬂict of interest statement
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